Kayfanda® (odevixibat) approved as new treatment choice for cholestatic pruritus in children from six months with the rare liver condition, Alagille Syndrome E.U. marketing authorization for Kayfanda ...
Z is a fifth-letter identifier for Nasdaq stock symbols. It indicates that a stock is different from a single issue of common or capital stock. Z might indicate that the issue is a depositary receipt, ...